Analgesics in Finland is set to experience a moderate contraction in 2026, with retail value dropping by 3% to EUR105 million, reflecting a return to pre-pandemic demand patterns seen across Western Europe. Nevertheless, the outlook remains attractive due to an anticipated return to growth, with retail value forecast to reach EUR112 million by 2031 at a CAGR of 1%, driven by consumers’ readiness to pay a premium for fast and effective pain relief. Companies are facing increased competitive intensity as consumers shift from established leaders towards more affordable alternatives and innovative launches, such as fast-dissolving systemic analgesics and non-diclofenac topical solutions, while regulatory changes enabling sales through grocery channels are set to disrupt established pharmacy distribution models. To succeed, brands must prioritise rapid product innovation, differentiation based on functional benefits and sustainability credentials, while pharmacies will need to defend their position by expanding product sophistication and enhancing customer experience in the face of digital growth.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Finland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Finland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Finland report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Finland?
- Which are the leading brands in Analgesics in Finland?
- How are products distributed in Analgesics in Finland?
- How has the regulatory and operating environment for Analgesics changed in Finland?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Sales slip in the face of declining demand
Regulatory change prompts pharmacies to innovate
Environmental concerns influence consumer choices
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Parents will increase spending on child-specific pain relief
New launches will affect competition and pricing
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Vitabalans and Harmonia Life challenge Orion’s lead as value brands gain ground
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain dominance as e-commerce builds momentum
Multi-channel pharmacies expand online reach, but face limits
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!